UTICA, N.Y. (AP) _ Conmed Corp. (CNMD) on Wednesday reported a second-quarter loss of $27.4 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Utica, New York-based company said it had a loss of 96 cents. Losses, adjusted for non-recurring costs and amortization costs, were 7 cents per share.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.02 per share.
The medical technology company posted revenue of $157.8 million in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $129.1 million.
Conmed shares have fallen 23% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $86.41, falling slightly in the last 12 months.